Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria

Aims To study the population pharmacokinetics of piperaquine after co‐administration with dihydroartemisinin in uncomplicated malaria.

Methods The disposition of piperaquine was studied in 85 Cambodian patients with uncomplicated falciparum or vivax malaria treated with the piperaquine‐dihydroartemisinin coformulation Artekin^®. All patients were given Artekin^® orally at 0, 6, 24 and 32 h with a total piperaquine dose of 32–35 mg base kg⁻¹. Adults were given tablets while children received either tablets or a dispersible granule formulation. Patients underwent either intensive (17–19 samples) or sparse (2–5 samples) blood sampling schedules over 35 days and clinical/parasitological follow‐up over > 28 days. Piperaquine in plasma was quantified by high performance liquid chromatography.

Results All patients achieved fever clearance within 24 h and parasite clearance within 72 h. The 28‐day cure rate was 97% in adults and 98% in children. A covariate‐free two‐compartment population model with first‐order absorption and elimination gave the most robust representation of the plasma concentration‐time data in both adults and children. In adults (n = 38), the median (interquartile range) derived pharmacokinetic descriptors CL/F, V_ss/F and t_1/2,z were 0.9 l h⁻¹ kg⁻¹ (0.79–1.02 l h⁻¹ kg⁻¹), 574 l kg⁻¹(371–711 l kg⁻¹) and 23 days (19–28 days), respectively. In children (n = 47), corresponding values were 1.8 l h⁻¹ kg⁻¹ (1.29–2.3 l h⁻¹ kg⁻¹), 614 l kg⁻¹ (332–1205 l kg⁻¹) and 14 days (10–18 days), respectively.

Conclusions Piperaquine is a highly lipid‐soluble drug with a large V_ss/F, long t_1/2,z and a clearance that is markedly higher in children than in adults.

DOI: 10.1046/j.1365-2125.2003.02004.x

View this article

• Full article (html)
• Enhanced article (html)
• PDF
• References